Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000450 |
Aldosterone |
Aldosterone results in increased expression of AGTR2 mRNA | increases expression | 15809360
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of AGTR2 mRNA | affects expression | 16483693
|
D000728 |
Androgens |
Androgens affects the expression of AGTR2 mRNA | affects expression | 17237611
|
D002251 |
Carbon Tetrachloride |
AGTR2 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of ACTA2 mRNA] | increases expression|increases reaction | 16774739
|
D002251 |
Carbon Tetrachloride |
AGTR2 gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of TGFB1 mRNA] | increases expression|increases reaction | 16774739
|
D002251 |
Carbon Tetrachloride |
AGTR2 gene mutant form results in increased susceptibility to Carbon Tetrachloride | increases response to substance | 16774739
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of AGTR2 mRNA | increases expression | 12832660
|
C060894 |
CGP 42112A |
CGP 42112A binds to and results in increased activity of AGTR2 protein | affects binding|increases activity | 19151255
|
C060894 |
CGP 42112A |
[CGP 42112A binds to and results in increased activity of AGTR2 protein] which affects the susceptibility to Phenylephrine | affects binding|affects response to substance|increases activity | 19151255
|
C060894 |
CGP 42112A |
CGP 42112A binds to and results in increased activity of AGTR2 protein | affects binding|increases activity | 16025228
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of AGTR2 mRNA | increases expression | 14722030
|
D004054 |
Diethylstilbestrol |
Diethylstilbestrol results in increased expression of AGTR2 protein | increases expression | 14722030
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AGTR2 mRNA | affects cotreatment|increases expression | 17942748
|
C473027 |
GW 3965 |
GW 3965 affects the expression of AGTR2 mRNA | affects expression | 17420776
|
D008070 |
Lipopolysaccharides |
AGTR2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA] | decreases reaction|increases expression | 19118600
|
D008070 |
Lipopolysaccharides |
AGTR2 protein inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA] | decreases reaction|increases expression | 19118600
|
D008070 |
Lipopolysaccharides |
AGTR2 protein promotes the reaction [Lipopolysaccharides results in increased expression of TGFB1 mRNA] | increases expression|increases reaction | 19118600
|
D008070 |
Lipopolysaccharides |
Lipopolysaccharides results in increased expression of AGTR2 mRNA | increases expression | 19118600
|
D008070 |
Lipopolysaccharides |
phenylmethylpyrazolone inhibits the reaction [Lipopolysaccharides results in increased expression of AGTR2 mRNA] | decreases reaction|increases expression | 19118600
|
D019808 |
Losartan |
Losartan results in increased expression of AGTR2 protein | increases expression | 18300857
|
D009569 |
Nitric Oxide |
AGTR2 protein affects the susceptibility to Nitric Oxide | affects response to substance | 9374809
|
C007350 |
nitrofen |
nitrofen results in decreased expression of AGTR2 mRNA | decreases expression | 16292651 15578192
|
D009638 |
Norepinephrine |
AGTR2 protein affects the susceptibility to Norepinephrine | affects response to substance | 11714657
|
D010047 |
Ovalbumin |
Ovalbumin results in decreased expression of AGTR2 mRNA | decreases expression | 19080339
|
D010100 |
Oxygen |
Oxygen deficiency results in increased expression of AGTR2 mRNA | increases expression | 16769992
|
D010100 |
Oxygen |
Oxygen deficiency results in increased expression of AGTR2 mRNA | increases expression | 19118600
|
D010100 |
Oxygen |
Oxygen deficiency results in increased expression of AGTR2 protein | increases expression | 19118600
|
C073402 |
PD 123319 |
PD 123319 binds to and results in decreased activity of AGTR2 protein | affects binding|decreases activity | 15807884
|
C073402 |
PD 123319 |
PD 123319 binds to and results in decreased activity of AGTR2 protein | affects binding|decreases activity | 18300857 19151255
|
C073402 |
PD 123319 |
[PD 123319 binds to and results in decreased activity of AGTR2 protein] which affects the susceptibility to Phenylephrine | affects binding|affects response to substance|decreases activity | 19151255
|
C073402 |
PD 123319 |
PD 123319 binds to and affects the activity of AGTR2 protein | affects activity|affects binding | 14630723
|
C073402 |
PD 123319 |
PD 123319 binds to and results in decreased activity of AGTR2 protein | affects binding|decreases activity | 18434761
|
D010656 |
Phenylephrine |
AGTR2 protein affects the susceptibility to Phenylephrine | affects response to substance | 11714657
|
D010656 |
Phenylephrine |
[CGP 42112A binds to and results in increased activity of AGTR2 protein] which affects the susceptibility to Phenylephrine | affects binding|affects response to substance|increases activity | 19151255
|
D010656 |
Phenylephrine |
[PD 123319 binds to and results in decreased activity of AGTR2 protein] which affects the susceptibility to Phenylephrine | affects binding|affects response to substance|decreases activity | 19151255
|
C005435 |
phenylmethylpyrazolone |
phenylmethylpyrazolone inhibits the reaction [Lipopolysaccharides results in increased expression of AGTR2 mRNA] | decreases reaction|increases expression | 19118600
|
D010852 |
Picrotoxin |
Picrotoxin results in decreased expression of AGTR2 mRNA | decreases expression | 15170462
|
C060836 |
pioglitazone |
[ANGPT2 protein binds to and results in increased activity of AGTR2 protein] promotes the reaction [pioglitazone binds to and results in increased activity of PPARG protein] | affects binding|increases activity|increases reaction | 15992368
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of AGTR2 mRNA | increases expression | 12832660
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of AGTR2 protein | increases expression | 18300857
|
D012965 |
Sodium Chloride |
AGTR2 protein inhibits the reaction [Sodium Chloride results in increased activity of AGT protein] | decreases reaction|increases activity | 15809360
|
D012965 |
Sodium Chloride |
Sodium Chloride results in decreased expression of AGTR2 mRNA | decreases expression | 15809360
|
D012965 |
Sodium Chloride |
Sodium Chloride results in decreased expression of AGTR2 protein | decreases expression | 15809360
|
D013311 |
Streptozocin |
Streptozocin results in increased expression of AGTR2 mRNA | increases expression | 17724226
|
D013311 |
Streptozocin |
Streptozocin results in increased expression of AGTR2 protein | increases expression | 17724226
|
D013974 |
Thyroxine |
Thyroxine results in increased expression of AGTR2 mRNA | increases expression | 18093424
|
D013654 |
Taurine |
Taurine results in decreased expression of AGTR2 protein | decreases expression | 16025228
|
D013739 |
Testosterone |
Testosterone affects the expression of AGTR2 mRNA | affects expression | 17237611
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of AGTR2 mRNA | affects cotreatment|increases expression | 17942748
|
C081489 |
valsartan |
valsartan inhibits the reaction [AGT protein results in increased expression of AGTR2 mRNA] | decreases reaction|increases expression | 11403356
|
C081489 |
valsartan |
valsartan inhibits the reaction [AGT protein results in increased expression of AGTR2 protein] | decreases reaction|increases expression | 11403356
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.61 | 11752688 15322242 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.31 | 18287403 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
3.69 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
Lipopolysaccharides |
14.04 | 11850527 18653653 |
MESH:D055371 |
Acute Lung Injury |
|
Oxygen |
14.04 | 16759491 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
14.04 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.75 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.08 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.08 | 16835633 |
MESH:D000419 |
Albuminuria |
|
Losartan |
5.61 | 12586211 |
MESH:D000544 |
Alzheimer Disease |
|
Androgens |
4.89 | 17182789 17917157 |
MESH:D000544 |
Alzheimer Disease |
|
Nitric Oxide |
4.89 | 17556102 |
MESH:D000686 |
Amyloidosis |
|
Diethylstilbestrol |
4.24 | 15469931 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.73 | 11748828 |
MESH:D000860 |
Anoxia |
|
Oxygen |
4.81 | 20872349 |
MESH:D000987 |
Antisocial Personality Disorder |
|
Testosterone |
5.61 | 7506515 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Phenylephrine |
3.90 | 17460149 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.22 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.51 | 15885639 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
phenylmethylpyrazolone |
3.73 | 16390820 |
MESH:D050197 |
Atherosclerosis |
|
Losartan |
7.06 | 10821809 |
MESH:D050197 |
Atherosclerosis |
|
Oxygen |
7.06 | 16391483 |
MESH:D001321 |
Autistic Disorder |
|
Norepinephrine |
3.10 | 8570775 |
MESH:D001321 |
Autistic Disorder |
|
pioglitazone |
3.10 | 17207275 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
8.04 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
8.04 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.54 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.61 | 15746008 |
MESH:D001919 |
Bradycardia |
|
Phenylephrine |
4.30 | 15306635 |
MESH:D001943 |
Breast Neoplasms |
|
Androgens |
2.86 | 17018787 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylstilbestrol |
2.86 | 17129689 15324884 |
MESH:D001943 |
Breast Neoplasms |
|
Nitric Oxide |
2.86 | 15631943 |
MESH:D001943 |
Breast Neoplasms |
|
Oxygen |
2.86 | 17263869 |
MESH:D001943 |
Breast Neoplasms |
|
Testosterone |
2.86 | 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.86 | 20435547 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ovalbumin |
5.17 | 12794006 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.54 | 16050911 15700767 16192424 15673190 10355542 16227642 3786805 15721981 16097048 16011737 18705752 16124888 |
MESH:D002276 |
Carcinoid Tumor |
|
Streptozocin |
5.35 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.61 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
3.04 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylstilbestrol |
3.04 | 16924424 15948411 |
MESH:D006332 |
Cardiomegaly |
|
Losartan |
25.06 | 12586211 15969258 |
MESH:D006332 |
Cardiomegaly |
|
Norepinephrine |
25.06 | 11179087 |
MESH:D006332 |
Cardiomegaly |
|
Phenylephrine |
25.06 | 15728586 17124262 11179087 16170337 11754973 17287366 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
25.06 | 18670907 18850075 16120746 |
MESH:D006332 |
Cardiomegaly |
|
Thyroxine |
25.06 | 18093424 |
MESH:D006332 |
Cardiomegaly |
|
valsartan |
25.06 | 19597038 |
MESH:D009202 |
Cardiomyopathies |
|
valsartan |
4.28 | 16247790 |
MESH:D002318 |
Cardiovascular Diseases |
|
Aldosterone |
7.78 | 11230374 |
MESH:D002318 |
Cardiovascular Diseases |
|
valsartan |
7.78 | 11230374 |
MESH:D002375 |
Catalepsy |
|
Norepinephrine |
5.29 | 8216760 |
MESH:D002543 |
Cerebral Hemorrhage |
|
phenylmethylpyrazolone |
5.58 | 19095969 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Testosterone |
3.59 | 20678186 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.96 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
12.51 | 16919318 17110522 11677210 17333356 17681005 15861022 16105132 |
MESH:D002779 |
Cholestasis |
|
Nitric Oxide |
12.51 | 16919318 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
12.51 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.00 | 12621046 8697196 15340226 16354765 15668235 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.85 | 14669216 17141729 |
MESH:D003324 |
Coronary Artery Disease |
|
valsartan |
3.81 | 17719468 |
MESH:D003384 |
Coxsackievirus Infections |
|
valsartan |
5.60 | 20392896 |
MESH:D019465 |
Craniofacial Abnormalities |
|
nitrofen |
2.86 | 11405365 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.86 | 15322242 20055451 10048152 |
MESH:D016638 |
Critical Illness |
|
Androgens |
5.81 | 16670151 |
MESH:D003456 |
Cryptorchidism |
|
Diethylstilbestrol |
4.32 | 12952375 16002989 |
MESH:D003550 |
Cystic Fibrosis |
|
pioglitazone |
4.71 | 19747007 |
MESH:D015140 |
Dementia, Vascular |
|
Nitric Oxide |
5.71 | 17556102 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.31 | 18249437 |
MESH:D003920 |
Diabetes Mellitus |
|
Streptozocin |
4.52 | 16285004 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Streptozocin |
8.48 | 17874149 15862027 16286809 7637645 19586609 18603373 11055810 12446591 18715473 19496084 15831366 2177838 12083368 19298542 11260395 6379147 17442507 12093613 16684804 8740154 15298345 19960420 12644472 1374869 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
valsartan |
8.48 | 11508273 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Streptozocin |
3.56 | 18603373 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
pioglitazone |
7.06 | 16023994 12642470 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Streptozocin |
7.06 | 19647726 19586609 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
7.06 | 17107852 |
MESH:D058065 |
Diabetic Cardiomyopathies |
marker/mechanism |
|
| 16025228 |
MESH:D058065 |
Diabetic Cardiomyopathies |
|
Streptozocin |
12.78 | 16025228 |
MESH:D058065 |
Diabetic Cardiomyopathies |
|
Taurine |
12.78 | 16025228 |
MESH:D003928 |
Diabetic Nephropathies |
|
Streptozocin |
9.10 | 19682444 19960420 |
MESH:D003928 |
Diabetic Nephropathies |
|
valsartan |
9.10 | 11427623 18630688 |
MESH:D003930 |
Diabetic Retinopathy |
|
Streptozocin |
5.19 | 17662242 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
5.95 | 21278145 10092053 10915739 2869522 7440962 7179309 15968718 6884620 9327722 19336974 4309450 15027814 17522070 16227642 6623471 3732212 11566570 16177239 7120509 15998439 3786805 19085960 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Taurine |
5.95 | 9328219 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
5.95 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
phenylmethylpyrazolone |
7.95 | 12231392 12649298 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.95 | 11462148 |
MESH:D004417 |
Dyspnea |
|
Oxygen |
4.58 | 20016425 |
MESH:D004487 |
Edema |
|
pirinixic acid |
5.82 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
5.82 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.65 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
2.95 | 12538720 |
MESH:D004714 |
Endometrial Hyperplasia |
|
Diethylstilbestrol |
4.45 | 16402032 |
MESH:D016889 |
Endometrial Neoplasms |
|
Diethylstilbestrol |
3.31 | 16804899 15700306 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.81 | 9294722 10568697 |
MESH:D019446 |
Endotoxemia |
|
Lipopolysaccharides |
10.18 | 17637181 15328337 15821434 |
MESH:D019446 |
Endotoxemia |
|
phenylmethylpyrazolone |
10.18 | 12954792 |
MESH:D004802 |
Eosinophilia |
|
Ovalbumin |
5.23 | 12689652 |
MESH:D004827 |
Epilepsy |
|
Norepinephrine |
4.17 | 821787 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.83 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
17.01 | 16239168 19224547 17595544 16045604 12795759 61145 15959796 12631006 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
17.01 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
phenylmethylpyrazolone |
17.01 | 12795759 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
17.01 | 19236843 20131406 |
MESH:D052776 |
Female Urogenital Diseases |
|
Diethylstilbestrol |
3.51 | 16002989 16534752 15751030 16611131 16513791 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.21 | 11858732 |
MESH:D005334 |
Fever |
|
Lipopolysaccharides |
3.80 | 9205823 11852909 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
13.53 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
13.53 | 20067830 |
MESH:D005355 |
Fibrosis |
|
valsartan |
13.53 | 16893502 |
MESH:D005391 |
Firesetting Behavior |
|
Testosterone |
5.61 | 7506515 |
MESH:D005739 |
Gas Poisoning |
|
Oxygen |
4.97 | 20016425 |
MESH:D005833 |
Genital Neoplasms, Female |
|
Diethylstilbestrol |
4.70 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Testosterone |
3.89 | 17162496 |
MESH:D015432 |
Glomerulonephritis, Membranoproliferative |
|
valsartan |
5.31 | 16928621 |
MESH:D005923 |
Glomerulosclerosis, Focal Segmental |
|
pioglitazone |
5.05 | 16687628 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.34 | 10696789 |
MESH:D006261 |
Headache |
|
Nitric Oxide |
4.93 | 11284996 11554966 |
MESH:D006330 |
Heart Defects, Congenital |
|
nitrofen |
6.59 | 16080930 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.59 | 10048152 11294989 |
MESH:D006331 |
Heart Diseases |
|
Streptozocin |
4.11 | 12093613 |
MESH:D006333 |
Heart Failure |
|
Losartan |
11.27 | 10979640 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
11.27 | 20558911 |
MESH:D006333 |
Heart Failure |
|
valsartan |
11.27 | 19027736 |
MESH:D006463 |
Hemolytic-Uremic Syndrome |
|
Lipopolysaccharides |
4.17 | 16366002 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.12 | 11000095 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.36 | 19900420 19110552 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
7.46 | 16221962 18467677 19176532 19772884 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
7.46 | 15340226 16120746 12621046 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
nitrofen |
3.85 | 17270546 7760232 10898222 17245593 15707848 12505043 7576705 12547725 15764645 18280292 16863852 16473863 10370017 18280291 10359170 9476886 9575882 16080930 16292651 8863223 9473106 15793718 11685700 15136996 10898224 11076806 17618886 16490937 10370016 15088113 15185205 12746050 11051153 12194112 11057544 11588001 11409163 15756563 10646786 12904592 11584395 16720372 9698600 18958481 12407540 15578192 9859898 12759764 10693666 10541330 7520565 12021965 11329586 |
MESH:D006628 |
Hirsutism |
|
Androgens |
12.81 | 16914592 17019078 |
MESH:D006628 |
Hirsutism |
|
Testosterone |
12.81 | 17019078 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.80 | 8697196 18606429 16959395 15340226 16354765 |
MESH:D017588 |
Hyperandrogenism |
|
Androgens |
11.50 | 17019078 |
MESH:D017588 |
Hyperandrogenism |
|
Testosterone |
11.50 | 17019078 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.28 | 16899240 |
MESH:D006940 |
Hyperemia |
|
Nitric Oxide |
5.37 | 11156591 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
2.97 | 20558911 |
MESH:D006965 |
Hyperplasia |
|
Diethylstilbestrol |
4.19 | 12960047 14722030 |
MESH:D006973 |
Hypertension |
|
Losartan |
15.46 | 14597852 10090350 12512695 12586211 15969258 |
MESH:D006973 |
Hypertension |
|
Phenylephrine |
15.46 | 8949925 12717712 |
MESH:D006973 |
Hypertension |
|
Sodium Chloride |
15.46 | 11507004 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
15.46 | 18670907 18850075 |
MESH:D006973 |
Hypertension |
|
valsartan |
15.46 | 18344623 18390891 12692753 11427623 12850387 16475468 10903974 20102058 |
MESH:D006974 |
Hypertension, Malignant |
|
valsartan |
6.16 | 11560862 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.85 | 15338365 |
MESH:D006976 |
Hypertension, Pulmonary |
|
Nitric Oxide |
4.24 | 15838368 |
MESH:D006984 |
Hypertrophy |
|
Phenylephrine |
4.33 | 12791704 18502941 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
phenylmethylpyrazolone |
5.19 | 15824197 |
MESH:D007006 |
Hypogonadism |
|
Testosterone |
4.41 | 12002444 |
MESH:D007018 |
Hypopituitarism |
|
Testosterone |
5.95 | 17426086 |
MESH:D007021 |
Hypospadias |
|
Diethylstilbestrol |
10.44 | 16002989 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
10.44 | 16945680 16569931 |
MESH:D007022 |
Hypotension |
|
Norepinephrine |
4.77 | 6740701 |
MESH:D007174 |
Impulse Control Disorders |
|
Testosterone |
5.61 | 7506515 |
MESH:D007246 |
Infertility |
|
Diethylstilbestrol |
4.12 | 15036965 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.23 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
2.33 | 17937319 |
MESH:D007249 |
Inflammation |
|
Lipopolysaccharides |
11.07 | 12878042 9205823 17237260 17255318 17963957 |
MESH:D007249 |
Inflammation |
|
Losartan |
11.07 | 12586211 |
MESH:D007249 |
Inflammation |
|
pioglitazone |
11.07 | 16908763 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
11.07 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.47 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Nitric Oxide |
4.69 | 11574821 11713966 10210152 |
MESH:D002532 |
Intracranial Aneurysm |
|
phenylmethylpyrazolone |
5.04 | 19381132 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Lipopolysaccharides |
4.40 | 17255318 |
MESH:D007511 |
Ischemia |
|
phenylmethylpyrazolone |
5.30 | 16301206 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.12 | 16580747 |
MESH:D007674 |
Kidney Diseases |
|
phenylmethylpyrazolone |
9.82 | 18085390 |
MESH:D007674 |
Kidney Diseases |
|
Streptozocin |
9.82 | 12093613 |
MESH:D007674 |
Kidney Diseases |
|
valsartan |
9.82 | 12164870 10903974 16893502 |
MESH:D007680 |
Kidney Neoplasms |
|
Diethylstilbestrol |
3.27 | 15003126 14681315 16762066 |
MESH:D007859 |
Learning Disorders |
|
Diethylstilbestrol |
3.82 | 17184923 |
MESH:D007896 |
Leishmaniasis |
|
Nitric Oxide |
4.45 | 17218153 |
MESH:D016773 |
Leishmaniasis, Cutaneous |
|
Sodium Chloride |
4.73 | 9499605 |
MESH:D007970 |
Leukopenia |
|
Lipopolysaccharides |
4.45 | 15821434 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
2.67 | 17334410 21278145 17174718 17157831 16221502 11903743 11408273 16943688 16239168 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
12.69 | 18156304 15338365 18429990 18412020 18263696 15362042 14716833 18395914 15959796 17721639 12632512 15996030 16192424 17714472 12958196 15123356 17631135 18339082 16027843 15818738 17766677 18210741 18420326 17708605 12609069 18376398 18395095 12586293 15876570 18251166 17640975 12741479 12445421 18205269 17976157 10355542 16011737 16248980 12667390 17805973 17525996 17761835 18418968 18279442 13678700 16015684 16033810 12898905 16097048 15370692 17900296 12632514 18187930 12666154 15052691 15893842 15650968 18166357 15931870 14724832 15925388 18472094 17481882 14716496 17557913 18705752 17944888 15730626 18054572 20821823 16136751 12445418 17922224 18317297 17565644 18006644 17698563 17869086 18481824 12389079 15673190 12546737 16116963 14748882 11481614 12649538 14620537 17823541 16638106 14512876 18277467 18472332 15057751 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Lipopolysaccharides |
12.69 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Losartan |
12.69 | 15573910 17900296 12445418 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pioglitazone |
12.69 | 15052691 16484506 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
12.69 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Taurine |
12.69 | 15893842 15931870 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
12.69 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
valsartan |
12.69 | 16872305 15619341 15504291 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.03 | 16246199 16964402 15720792 15830285 17285989 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.92 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.48 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
9.90 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylstilbestrol |
9.90 | 16712894 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
9.90 | 16377806 15890375 20007298 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
9.90 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
5.26 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
5.26 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
nitrofen |
4.25 | 9614859 16863852 9859898 17245593 |
MESH:D055370 |
Lung Injury |
|
Lipopolysaccharides |
14.03 | 21114838 |
MESH:D055370 |
Lung Injury |
|
Nitric Oxide |
14.03 | 11395602 |
MESH:D055370 |
Lung Injury |
|
Oxygen |
14.03 | 18339021 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
1.23 | 19555203 11884234 |
MESH:D008181 |
Lupus Nephritis |
|
Diethylstilbestrol |
4.90 | 15166399 |
MESH:D008223 |
Lymphoma |
|
Diethylstilbestrol |
7.47 | 15700306 |
MESH:D008223 |
Lymphoma |
|
Nitric Oxide |
7.47 | 16166326 |
MESH:D052801 |
Male Urogenital Diseases |
|
Diethylstilbestrol |
5.27 | 16002989 |
MESH:D008382 |
Marfan Syndrome |
|
Losartan |
5.83 | 19430350 |
MESH:D038901 |
Mental Retardation, X-Linked |
marker/mechanism |
|
| |
MESH:D008659 |
Metabolic Diseases |
|
phenylmethylpyrazolone |
5.26 | 16301206 |
MESH:D008881 |
Migraine Disorders |
|
Nitric Oxide |
4.11 | 11701602 |
MESH:D020326 |
Migraine without Aura |
|
Nitric Oxide |
4.88 | 11304026 14659530 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.27 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
Losartan |
5.85 | 12692751 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.85 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.83 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Norepinephrine |
8.21 | 15642760 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
8.21 | 16411023 |
MESH:D009369 |
Neoplasms |
|
Diethylstilbestrol |
4.64 | 15313581 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
4.64 | 17405874 |
MESH:D009421 |
Nervous System Malformations |
|
Diethylstilbestrol |
8.86 | 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
8.86 | 14600291 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.75 | 20558911 |
MESH:D010195 |
Pancreatitis |
|
phenylmethylpyrazolone |
4.66 | 20035747 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.46 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.00 | 12520081 |
MESH:D010900 |
Pituitary Diseases |
|
Diethylstilbestrol |
4.92 | 14722030 |
MESH:D010911 |
Pituitary Neoplasms |
|
Diethylstilbestrol |
4.43 | 16977796 15687265 |
MESH:D011014 |
Pneumonia |
|
Lipopolysaccharides |
4.31 | 12224865 11605937 |
MESH:D011015 |
Pneumonia, Aspiration |
|
Nitric Oxide |
5.09 | 18573544 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.32 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Diethylstilbestrol |
8.75 | 17184923 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.75 | 11222880 11896295 11399792 11118676 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Testosterone |
4.83 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Androgens |
4.00 | 17909013 15389811 16998812 |
MESH:D011471 |
Prostatic Neoplasms |
|
Diethylstilbestrol |
4.00 | 15846301 17136230 15046698 |
MESH:D011507 |
Proteinuria |
|
pioglitazone |
9.39 | 16687628 |
MESH:D011507 |
Proteinuria |
|
valsartan |
9.39 | 17664856 18344623 12164870 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.07 | 15861022 16919318 |
MESH:D011658 |
Pulmonary Fibrosis |
|
valsartan |
3.72 | 17241526 |
MESH:D051437 |
Renal Insufficiency |
|
Losartan |
5.28 | 15728788 |
MESH:D015427 |
Reperfusion Injury |
|
phenylmethylpyrazolone |
6.58 | 16041266 15948865 16753835 15086910 14654979 15629865 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.58 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oxygen |
4.28 | 17627322 18339021 |
MESH:D012130 |
Respiratory Hypersensitivity |
|
Lipopolysaccharides |
3.57 | 10835634 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.60 | 18990726 |
MESH:D012220 |
Rhinitis |
|
Ovalbumin |
5.19 | 18298128 12689652 |
MESH:D012555 |
Schistosomiasis mansoni |
|
Nitric Oxide |
5.21 | 9673227 |
MESH:D012640 |
Seizures |
|
Picrotoxin |
3.83 | 8954991 8635557 |
MESH:D012735 |
Sexual Dysfunction, Physiological |
|
Testosterone |
5.95 | 16631401 |
MESH:D012852 |
Sinusitis |
|
Phenylephrine |
4.46 | 7327846 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
1.93 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Diethylstilbestrol |
10.88 | 16002989 16709447 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
10.88 | 16709447 |
MESH:D013274 |
Stomach Neoplasms |
|
Sodium Chloride |
3.37 | 16646055 |
MESH:D013276 |
Stomach Ulcer |
|
Nitric Oxide |
3.98 | 15138204 |
MESH:D013398 |
Sudden Infant Death |
|
Oxygen |
5.30 | 12563064 |
MESH:D013610 |
Tachycardia |
|
Norepinephrine |
5.20 | 3261545 |
MESH:D013921 |
Thrombocytopenia |
|
Lipopolysaccharides |
3.95 | 15821434 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.39 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
2.95 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
11.54 | 12697716 |
MESH:D013959 |
Thyroid Diseases |
|
Thyroxine |
11.54 | 19910387 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Diethylstilbestrol |
2.68 | 16452187 17306315 16712894 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Diethylstilbestrol |
3.82 | 16175088 |
MESH:D014591 |
Uterine Diseases |
|
Diethylstilbestrol |
4.92 | 14652134 |
MESH:D014594 |
Uterine Neoplasms |
|
Diethylstilbestrol |
8.69 | 16690809 15809267 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
8.69 | 14692618 |
MESH:D014625 |
Vaginal Neoplasms |
|
Diethylstilbestrol |
4.19 | 16513791 16002989 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.34 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.32 | 14671159 15869587 |
MESH:D020257 |
Ventricular Remodeling |
|
valsartan |
5.45 | 19027736 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.00 | 15886252 |